£176.99

Hepatic Steatosis: Clinical Risk Factors, Molecular Mechanisms and Treatment Outcomes (Hepatology Research and Clinical Developments)

Internal Medicine

Price data last checked 90 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £177 (1 days, 100.0%)

Price range: £177 - £177

Price levels: 1 different prices over 1 days

Description

In the last few years, human metabolic disorders have become some of the most prevalent and prejudicial diseases worldwide. Hepatic steatosis, among many health problems, has several risk factors related to the disease prognosis such as obesity, nutritional problems, diabetes, hypertension, hyperuricemia, and even sleep apnea. Alcohol abuse also can lead to a severe liver-steatosis state. The progression of hepatic steatosis can lead to complications such as cryptogenic cirrhosis and hepatocellular carcinoma. Drug therapy has instead been focused on the mitigation of risk factors, however new potential therapeutic perspectives are being discussed. This book presents the origins, diagnosis and epidemiology of hepatic steatosis with new perceptions. The authors also aimed to show the molecular basis and signaling involved in liver disorders, discussing the inflammatory process, lipid metabolism and angiogenesis mechanisms. The role of nutrition in the treatment and development of steatosis was also presented and new advances were highlighted. Recent studies revealed the need for the use of bariatric surgery, functional foods and the modulation of endogenous systems, such as the sirtuins and renin-angiotensin systems, to treat liver disease. In this context, we aimed to introduce, review and discusses one of the most widespread metabolic disorders in the world: hepatic steatosis and its repercussions.

Product Specifications

Format: Hardcover
ASIN: 1633214036
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine
Domain: Amazon UK
Release Date: 01 September 2014
Listed Since: 14 June 2014

Barcode

No barcode data available

Hepatic Steatosis: Clinical Risk Factors, Molecular Mechanisms and Treatment Outcomes (Hepatology Research and Clinical Developments)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Nonalcoholic Fatty Liver Disease: New Insights

Metabolic Aspects of Chronic Liver Disease

Nonalcoholic Steatohepatitis (NASH): Symptoms, Risk Factors and Treatments: Symptoms, Risk Factors and Treatments (Hepatology Research and Clinical Developments)

CRC Press - Liver Metabolism and Fatty Liver Disease Book

Liver Cirrhosis and Related Diseases: Pathophysiology, Prognosis and Treatment

Nutrition, Diet Therapy, and the Liver

Nutrition, Diet Therapy, and the Liver

NASH and NAFLD, An Issue of Clinics in Liver Disease (Volume 22-1) (The Clinics: Internal Medicine, Volume 22-1)

NASH and Nutritional Therapy (Frontiers in Hepatology)

Hepatic Fibrosis: Mechanisms and Targets

New Developments in Liver Cirrhosis Research

Liver Pathophysiology: Therapies and Antioxidants

Fatty Liver Disease: NASH and Related Disorders

Metabolic Syndrome: A Comprehensive Textbook

The Liver Cirrhosis: New Research

Trends in Liver Cirrhosis Research - Nova Science Pub Inc

Molecular Pathology of Liver Diseases: 5 (Molecular Pathology Library, 5)

Cholestatic Liver Disease (Clinical Gastroenterology)

Humana Portal Hypertension: Pathobiology and Treatment Book

Vascular Liver Disease: Mechanisms and Management

Biliary Disease: From Science to Clinic

Biliary Disease: From Science to Clinic

Advances in Health and Disease: Volume 17

Motor Dysfunction, Etiology & Pathogenesis of Gallstones (Digestive Diseases - Research and Clinical Developments)